Yahoo Finance

Bio-AMD, Inc.; COAG PT/INR Point of Care Hemostasis Project & Patent Update

DARESBURY, UNITED KINGDOM--(Marketwired - May 12, 2016) - Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") (OTCQB: ...
News Medical

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

Globally, how many patients are estimated to be taking Warfarin and what are the main reasons the drug is prescribed? There are roughly 10 million people worldwide taking Warfarin, accounting for more ...
PR Newswire

Frost & Sullivan Applauds iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

The microINR system offers distinct advantages such as automatic calibration as well as multilevel quality control and low sample volume MOUNTAIN VIEW, California, Oct. 3, 2016 /PRNewswire/ -- Based ...
Medindia

New Handheld Base Unit for CoaguChek XS Plus System Enables Connectivity to RALS-Plus Data Management Solution for PT/INR Testing at the Point of Care

INDIANAPOLIS, Nov. 11 The U.S. Food and DrugAdministration has granted approval for the new Handheld Base Unit for theCoaguChek(R) XS Plus System, which provides connectivity between ...
Yahoo Finance

Bio-AMD, Inc. Second Quarter Update

DARESBURY, UNITED KINGDOM--(Marketwired - Aug 16, 2016) - Bio-AMD, Inc. and Bio-AMD UK Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") (OTCQB: ...
manilatimes

Coag-Sense® PT/INR Monitoring System Approved for Patient Self-Testing in Europe

FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense® PT/INR ...